Skip to main content
. Author manuscript; available in PMC: 2016 Jun 24.
Published in final edited form as: Gynecol Oncol. 2015 Jul 12;138(3):712–716. doi: 10.1016/j.ygyno.2015.07.014

Table 1.

Questions posed to expert panel regarding IV versus IP/IV chemotherapy for advanced ovarian cancer.

  1. Probability of ER/hospital visits during treatment

  2. Probability of completing six prescribed cycles of chemotherapy

  3. Probability of surviving 5 years

  4. Median survival time